Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News CalciMedica Inc CALC

Healthcare Biotechnology
CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic... see more

Recent & Breaking News (NDAQ:CALC)

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

PR Newswire November 12, 2025

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

PR Newswire November 12, 2025

CalciMedica Presents Data from Preclinical Study of Auxora(TM) in an Animal Model of AKI at ASN Kidney Week 2025

PR Newswire November 10, 2025

CalciMedica and Telperian Announce Collaboration to Integrate Innovative Artificial Intelligence Engine to Analysis of Clinical Trials of Auxora(TM)

PR Newswire October 14, 2025

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

PR Newswire September 2, 2025

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

PR Newswire August 12, 2025

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

PR Newswire July 8, 2025

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora(TM) in AKI with Respiratory Failure

PR Newswire June 25, 2025

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

PR Newswire June 12, 2025

CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

PR Newswire May 14, 2025

CalciMedica Announces Presentations at Upcoming Medical Meetings

PR Newswire April 17, 2025

CalciMedica to Participate in the Jones Healthcare and Technology Innovation Conference

PR Newswire April 1, 2025

CalciMedica Reports 2024 Financial Results and Provides Clinical & Corporate Updates

PR Newswire March 27, 2025

CalciMedica Secures Credit Facility for Up to $32.5 Million

PR Newswire March 5, 2025

CalciMedica Presents AKI Data from a Post-Hoc Analysis of the Phase 2 CARDEA trial of Auxora(TM) in Severe COVID-19 Pneumonia at the 30th International AKI & CRRT Conference

PR Newswire March 4, 2025

CalciMedica Announces Upcoming Plenary Presentation at the 30th International AKI & CRRT Conference

PR Newswire February 19, 2025

CalciMedica to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PR Newswire February 3, 2025

CalciMedica Announces Appointment of Dr. Alan Glicklich to Board of Directors

PR Newswire January 14, 2025

CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference

PR Newswire November 21, 2024

CalciMedica Announces Presentations at Upcoming Medical Meetings

PR Newswire November 20, 2024

Podcasts